Cytokinetics Inc (NASDAQ:CYTK)
| 22.30 Delayed Data As of 3:59pm ET |  +0.15 / +0.68%Today’s Change | 14.71 Today|||52-Week Range 30.14 | +7.31% Year-to-Date |
Latest CYTK News | Press Releases
No recent news for Cytokinetics Inc.
Today’s Trading
| Previous close | 22.15 |
| Today’s open | 22.18 |
| Day’s range | 21.96 - 22.41 |
| Volume | 17,086 |
| Average volume (3 months) | 872,866 |
| Market cap | $1.5B |
Data as of 3:59pm ET, 06/23/2021
Growth & Valuation
| Earnings growth (last year) | +6.66% |
| Earnings growth (this year) | -33.62% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +107.79% |
| P/E ratio | NM |
| Price/Sales | 24.02 |
| Price/Book | 13.35 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| KURAKura Oncology Inc | -0.12 | -0.56% |
| AMRXAmneal Pharmaceutica... | +0.01 | +0.19% |
| IRWDIronwood Pharmaceuti... | -0.19 | -1.51% |
| QTRXQuanterix Corp | +1.24 | +1.99% |
Data as of 4:00pm ET, 06/23/2021
Financials
| Next reporting date | July 29, 2021 |
| EPS forecast (this quarter) | -$0.66 |
| Annual revenue (last year) | $55.8M |
| Annual profit (last year) | -$127.3M |
| Net profit margin | -228.00% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
